Mesa Laboratories, Inc.
MLAB
$71.62
-$2.32-3.14%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.01% | -4.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.01% | -4.17% | |||
| Cost of Revenue | 3.55% | -4.72% | |||
| Gross Profit | 1.06% | -3.83% | |||
| SG&A Expenses | -4.61% | -9.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.83% | -6.90% | |||
| Operating Income | 54.18% | 108.58% | |||
| Income Before Tax | -71.49% | 1,421.04% | |||
| Income Tax Expenses | -121.01% | -70.03% | |||
| Earnings from Continuing Operations | -47.79% | 166.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.79% | 166.66% | |||
| EBIT | 54.18% | 108.58% | |||
| EBITDA | 17.20% | 0.61% | |||
| EPS Basic | -48.23% | 166.34% | |||
| Normalized Basic EPS | -71.73% | 1,413.02% | |||
| EPS Diluted | -47.15% | 164.98% | |||
| Normalized Diluted EPS | -71.40% | 1,389.06% | |||
| Average Basic Shares Outstanding | 0.86% | 0.48% | |||
| Average Diluted Shares Outstanding | -0.32% | 2.10% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.93% | 2.51% | |||